Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer.AuthorsIkeda, Masafumi; Ohno, Izumi; Ueno, Hideki; Mitsunaga, Shuichi; Hashimoto, Yusuke; Okusaka, Takuji; Kondo, Shunsuke; Sasaki, Mitsuhito; Sakamoto, Yasunari; Takahashi, Hideaki; Hara, Rina; Kobayashi, Shingo; Nakamura, Osamu; Morizane, ChigusaPublicationInvestigational New Drugs, 2019, Vol 37, Issue 1, p109ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0634-5